Chief Executive Officer
Thu, Sep 1, 2022
Sep 1
10,641 shares @ $23.15
Decreased holdings by -0.80%
Trade made by an officer
40% win rate · -7.5% median edge vs SPY (5 trades, 90-day · small sample)
Price 60% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology